Novel MHC class I structures on exosomes

Journal of Immunology

Volumn 183, Issue 3, 2009, Pages 1884-1891

  Lynch, Sarah ^a   Santos, Susana G ^a   Campbell, Elaine C ^a   Nimmo, Ailish M S ^a   Botting, Catherine ^b   Prescott, Alan ^c   Antoniou, Antony N ^d   Powis, Simon J ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DIMER; GLUTATHIONE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; CYSTEINE; DISULFIDE; HLA ANTIGEN CLASS 1;

ALLELE; ANTIGEN DETECTION; ANTIGEN STRUCTURE; ARTICLE; CELL LINE; CELL LYSATE; CONTROLLED STUDY; DENDRITIC CELL; DISULFIDE BOND; EXOSOME; HUMAN; HUMAN CELL; MONOCYTE; PLASMA; PRIORITY JOURNAL; CHEMISTRY; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION;

ALLELES; CYSTEINE; DISULFIDES; EXOSOMES; GLUTATHIONE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION;

EID: 68149099519     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900798     Document Type: Article

References (49)

1. Kim, S. H., E. R. Lechman, N. Bianco, R. Menon, A. Keravala, J. Nash, Z. Mi, S. C. Watkins, A. Gambotto, and P. D. Robbins. 2005. Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J. Immunol. 174: 6440-6448.
2. Lehmann, B. D., M. S. Paine, A. M. Brooks, J. A. McCubrey, R. H. Renegar, R. Wang, and D. M. Terrian. 2008. Senescence-associated exosome release from human prostate cancer cells. Cancer Res. 68: 7864-7871.
3. Raposo, G., H. W. Nijman, W. Stoorvogel, R. Liejendekker, C. V. Harding, C. J. Melief, and H. J. Geuze. 1996. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183: 1161-1172.
4. Wang, G. J., Y. Liu, A. Qin, S. V. Shah, Z. B. Deng, X. Xiang, Z. Cheng, C. Liu, J. Wang, L. Zhang, W. E. Grizzle, and H. G. Zhang. 2008. Thymus exosomeslike particles induce regulatory T cells. J. Immunol. 181: 5242-5248.
5. Johnstone, R. M., M. Adam, J. R. Hammond, L. Orr, and C. Turbide. 1987. Vesicle formation during reticulocyte maturation: association of plasma membrane activities with released vesicles (exosomes). J. Biol. Chem. 262: 9412-9420.
6. Faure, J., G. Lachenal, M. Court, J. Hirrlinger, C. Chatellard-Causse, B. Blot, J. Grange, G. Schoehn, Y. Goldberg, V. Boyer, et al. 2006. Exosomes are released by cultured cortical neurones. Mol. Cell Neurosci. 31: 642-648.
7. van Niel, G., G. Raposo, C. Candalh, M. Boussac, R. Hershberg, N. Cerf-Bensussan, and M. Heyman. 2001. Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology 121: 337-349. (Pubitemid 32729381)
8. Blanchard, N., D. Lankar, F. Faure, A. Regnault, C. Dumont, G. Raposo, and C. Hivroz. 2002. TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/ζ complex. J. Immunol. 168: 3235-3241.
9. Raposo, G., D. Tenza, S. Mecheri, R. Peronet, C. Bonnerot, and C. Desaymard. 1997. Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol. Biol Cell. 8: 2631-2645.
10. Zitvogel, L., A. Regnault, A. Lozier, J. Wolfers, C. Flament, D. Tenza, P. Ricciardi-Castagnoli, G. Raposo, and S. Amigorena. 1998. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4: 594-600.
11. Escudier, B., T. Dorval, N. Chaput, F. Andre, M. P. Caby, S. Novault, C. Flament, C. Leboulaire, C. Borg, S. Amigorena, et al. 2005. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial. J. Translational Med. (electronic resource) 3: 10.
12. Dai, S., D. Wei, Z. Wu, X. Zhou, X. Wei, H. Huang, and G. Li. 2008. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol. Ther. 16: 782-790.
13. Morse, M. A., J. Garst, T. Osada, S. Khan, A. Hobeika, T. M. Clay, N. Valente, R. Shreeniwas, M. A. Sutton, A. Delcayre, et al. 2005. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J. Translational Med. (electronic resource) 3: 9.
14. Antoniou, A. N., S. J. Powis, and T. Elliott. 2003. Assembly and export of MHC class I peptide ligands. Curr. Opin. Immunol. 15: 75-81.
15. Fooksman, D. R., G. K. Gronvall, Q. Tang, and M. Edidin. 2006. Clustering class I MHC modulates sensitivity of T cell recognition. J. Immunol. 176: 6673-6680.
16. Segura, J. M., P. Guillaume, S. Mark, D. Dojcinovic, A. Johannsen, G. Bosshard, G. Angelov, D. F. Legler, H. Vogel, and I. F. Luescher. 2008. Increased mobility of major histocompatibility complex I-peptide complexes decreases the sensitivity of antigen recognition. J. Biol. Chem. 283: 24254-24263.
17. Bryceson, Y. T., and E. O. Long. 2008. Line of attack: NK cell specificity and integration of signals. Curr. Opin. Immunol. 20: 344-352.
18. Allen, R. L., C. A. O'Callaghan, A. J. McMichael, and P. Bowness. 1999. Cutting edge: HLA-B27 can form a novel β 2-microglobulin-free heavy chain homodimer structure. J. Immunol. 162: 5045-5048.
19. Kollnberger, S., L. A. Bird, M. Roddis, C. Hacquard-Bouder, H. Kubagawa, H. C. Bodmer, M. Breban, A. J. McMichael, and P. Bowness. 2004. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors. J. Immunol. 173: 1699-1710.
20. Turner, M. J., D. P. Sowders, M. L. DeLay, R. Mohapatra, S. Bai, J. A. Smith, J. R. Brandewie, J. D. Taurog, and R. A. Colbert. 2005. HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response. J. Immunol. 175: 2438-2448.
21. Stam, N. J., H. Spits, and H. L. Ploegh. 1986. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J. Immunol. 137: 2299-2306.
22. Stam, N. J., T. M. Vroom, P. J. Peters, E. B. Pastoors, and H. L. Ploegh. 1990. HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in Western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. Int. Immunol. 2: 113-125.
23. Ellis, S. A., C. Taylor, and A. McMichael. 1982. Recognition of HLA-B27 and related antigen by a monoclonal antibody. Hum. Immunol. 5: 49-59.
24. Parham, P., and F. M. Brodsky. 1981. Partial purification and some properties of BB7.2: a cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum. Immunol. 3: 277-299.
25. Barnstable, C. J., W. F. Bodmer, G. Brown, G. Galfre, C. Milstein, A. F. Williams, and A. Ziegler. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 14: 9-20.
26. Hanke, T., P. Szawlowski, and R. E. Randall. 1992. Construction of solid matrixantibody- antigen complexes containing simian immunodeficiency virus p27 using tag-specific monoclonal antibody and tag-linked antigen. J. Gen. Virol. 73: 653-660.
27. Segura, E., C. Nicco, B. Lombard, P. Veron, G. Raposo, F. Batteux, S. Amigorena, and C. Thery. 2005. ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. Blood 106: 216-223.
28. Shevchenko, A., M. Wilm, O. Vorm, and M. Mann. 1996. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68: 850-858. (Pubitemid 26101214)
29. Antoniou, A. N., S. Ford, E. S. Pilley, N. Blake, and S. J. Powis. 2002. Interactions formed by individually expressed TAP1 and TAP2 polypeptide subunits. Immunology 106: 182-189.
30. Lemin, A. J., K. Saleki, M. van Lith, and A. M. Benham. 2007. Activation of the unfolded protein response and alternative splicing of ATF6α in HLA-B27 positive lymphocytes. FEBS Lett. 581: 1819-1824.
31. Ackerman, A. L., and P. Cresswell. 2003. Regulation of MHC class I transport in human dendritic cells and the dendritic-like cell line KG-1. J. Immunol. 170: 4178-4188.
32. Mignot, G., S. Roux, C. Thery, E. Segura, and L. Zitvogel. 2006. Prospects for exosomes in immunotherapy of cancer. J. Cell. Mol. Med. 10: 376-388.
33. Velikovsky, C. A., L. Deng, L. K. Chlewicki, M. M. Fernandez, V. Kumar, and R. A. Mariuzza. 2007. Structure of natural killer receptor 2B4 bound to CD48 reveals basis for heterophilic recognition in signaling lymphocyte activation molecule family. Immunity 27: 572-584.
34. Bowness, P. 2002. HLA B27 in health and disease: a double-edged sword? Rheumatology 41: 857-868.
35. Jessop, C. E., and N. J. Bulleid. 2004. Glutathione directly reduces an oxidoreductase in the endoplasmic reticulum of mammalian cells. J. Biol. Chem. 279: 55341-55347.
36. Momburg, F., V. Ortiz-Navarrete, J. Neefjes, E. Goulmy, Y. van de Wal, H. Spits, S. J. Powis, G. W. Butcher, J. C. Howard, P. Walden, et al. 1992. Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation. Nature 360: 174-177.
37. Hunt, D. F., R. A. Henderson, J. Shabanowitz, K. Sakaguchi, H. Michel, N. Sevilir, A. L. Cox, E. Appella, and V. H. Engelhard. 1992. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255: 1261-1263.
38. Capps, G. G., B. E. Robinson, K. D. Lewis, and M. C. Zuniga. 1993. In vivo dimeric association of class I MHC heavy chains: possible relationship to class I MHC heavy chain-β 2-microglobulin dissociation. J. Immunol. 151: 159-169.
39. Kollnberger, S., A. Chan, M. Y. Sun, L. Y. Chen, C. Wright, K. di Gleria, A. McMichael, and P. Bowness. 2007. Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide. Eur. J. Immunol. 37: 1313-1322.
40. Pisitkun, T., R. F. Shen, and M. A. Knepper. 2004. Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. USA 101: 13368-13373.
41. Wring, S. A., J. P. Hart, and B. J. Birch. 1989. Determination of glutathione in human plasma using high-performance liquid chromatography with electrochemical detection with a carbon-epoxy resin composite electrode chemically modified with cobalt phthalocyanine. Analyst 114: 1571-1573.
42. Gruda, R., H. Achdout, N. Stern-Ginossar, R. Gazit, G. Betser-Cohen, I. Manaster, G. Katz, T. Gonen-Gross, B. Tirosh, and O. Mandelboim. 2007. Intracellular cysteine residues in the tail of MHC class I proteins are crucial for extracellular recognition by leukocyte Ig-like receptor 1. J. Immunol. 179: 3655-3661.
43. Kaufman, J. F., M. S. Krangel, and J. L. Strominger. 1984. Cysteines in the transmembrane region of major histocompatibility complex antigens are fatty acylated via thioester bonds. J. Biol. Chem. 259: 7230-7238.
44. Chambers, J. E., C. E. Jessop, and N. J. Bulleid. 2008. Formation of a major histocompatibility complex class I tapasin disulfide indicates a change in spatial organization of the peptide-loading complex during assembly. J. Biol. Chem. 283: 1862-1869.
45. Mitra, A. K., H. Celia, G. Ren, J. G. Luz, I. A. Wilson, and L. Teyton. 2004. Supine orientation of a murine MHC class I molecule on the membrane bilayer. Curr. Biol. 14: 718-724.
46. Apps, R., L. Gardner, A. M. Sharkey, N. Holmes, and A. Moffett. 2007. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigenpresenting cells via LILRB1. Eur. J. Immunol. 37: 1924-1937.
47. Shiroishi, M., K. Kuroki, T. Ose, L. Rasubala, I. Shiratori, H. Arase, K. Tsumoto, I. Kumagai, D. Kohda, and K. Maenaka. 2006. Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. J. Biol. Chem. 281: 10439-10447.
48. Viaud, S., M. Terme, C. Flament, J. Taieb, F. Andre, S. Novault, B. Escudier, C. Robert, S. Caillat-Zucman, T. Tursz, L. Zitvogel, and N. Chaput. 2009. Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Rα. PLoS ONE 4: e4942.
49. Capps, G. G., and M. C. Zuniga. 1993. The cytoplasmic domain of the H-2Ld class I major histocompatibility complex molecule is differentially accessible to immunological and biochemical probes during transport to the cell surface. J. Biol. Chem. 268: 21263-21270.